Melanoma web sites give incomplete or wrong information, study finds

December 27, 2001

Patients should choose sites carefully, authors warn - and doctors should steer them to the best

ANN ARBOR, MI - Popular Internet sites devoted to melanoma may seem trustworthy, but the information they provide is often only skin-deep, a new University of Michigan study finds. In fact, the majority of sites studied had incomplete facts about the increasingly common and potentially deadly form of skin cancer, and about one in eight had an inaccuracy.

The results from the first study of its kind, published in the January Journal of Clinical Oncology, suggest that Web users should beware when searching for information on melanoma, and that their physicians should guide them toward sites that give full and correct details on the disease.

With more people turning to the Web for health information, especially after diagnosis, the researchers warn that incomplete sites could raise anxiety for those diagnosed with melanoma, mislead those at risk, and even undermine the relationship between doctors and patients.

"No one expects every Web site on a given topic to include every bit of information available, but the lack of even basic preventive, diagnostic, treatment and risk factor data on so many sites amazed us," says lead author Christopher Bichakjian, M.D., a lecturer in dermatology at the U-M Health System. "The fact that melanoma so often strikes young adults, who might be most likely to turn to the Internet for medical information, gives Web-site quality even more importance."

The study's authors - most of them dermatologists in the melanoma clinic of the U-M Health System's Comprehensive Cancer Center - often encounter skin cancer patients who come to appointments clutching printouts from Web sites, some of them misleading or inaccurate. So, the researchers conducted their study by putting themselves in their patients' shoes. They typed the word "melanoma" into six of the most popular commercial search engine services, as well as two well-known medical search engines.

After discarding more than 160 dead links, duplicates and pages with many links but no facts, they found 74 web sites that could be assessed against a "gold standard" checklist of 35 factors, from basic definitions and incidence rates to specific risk factors and treatment options.

Only eight of the factors were included on at least half the sites, and no one piece of information appeared on more than 62 percent of the sites.

Fourteen percent of sites had erroneous information. Most inaccuracies were relatively minor, but some were considerably more dangerous. "Some sites recommended unnecessary tests and more invasive, unnecessary surgery," says co-author Timothy M. Johnson, M.D., director of the U-M melanoma clinic and the William B. Taylor Professor of Dermatology.

Only 62 percent of sites even defined melanoma, while 59 percent correctly stated that the prognosis for someone diagnosed with it can range from death to disease-free survival, depending on what stage it's in when treated. Statistics on melanoma's incidence were also often missing - just 47 percent of sites included such information.

Skin cancers of all kinds are easy to spot because they appear on the surface of the body. Early detection can improve treatment effectiveness and survival. But surprisingly, less than a third of sites included images of melanomas, which could be powerful tools for those wondering if a spot on their skin might be dangerous. Just over half the sites listed signs and symptoms of melanoma, and 38 percent mentioned the importance of screening by oneself or a physician.

Prevention techniques and risk factors, which are key to avoiding melanoma or a recurrence, were also scarce. Sunscreen, hats or clothing, and avoidance of the midday sun were only mentioned on a third of sites. And the increased risks of melanoma that come with a history of sunburn, fair skin or hair, moles on the skin, or a personal or family history of the disease, were raised on less than half of sites.

For those seeking knowledge about diagnostic techniques and treatments for melanoma, the results weren't much better. About half the sites mentioned surgery to remove lesions, but less than a quarter mentioned diagnostic workups or sentinel lymph node biopsies, which can tell whether the cancer has begun to spread beyond the skin.

The sites evaluated in the research included offerings from government agencies, nonprofit organizations, medical professional societies, academic medical centers, companies and individual patients. Most were found using the commercial search engines Yahoo, MSN, Lycos, Netscape, Go and Excite, while the medical search engines Med Hunt and Medical World Search yielded surprisingly few.

Bichakjian and his colleagues cross-checked each others' evaluations of the sites, to ensure accuracy of their results. Their "gold standard" checklist came from National Comprehensive Cancer Center Network guidelines and multidisciplinary consensus expert guidelines.

The new study follows in the footsteps of a pioneering 1999 assessment of Internet health information accuracy, led by UMHS orthopaedic surgeon Sybil Biermann, M.D. Biermann - who is a co-author on the new paper and shared her methodology with the dermatologists - found many inaccuracies on sites dealing with Ewing's sarcoma, a rare bone cancer she treats.

"Unlike Ewing's sarcoma, there are things people can do to reduce their risk of melanoma - both to cut the chance their cancer will come back, and to help their relatives who are also at risk," she says. "That's why it's so important that the Internet help disseminate the information. Unfortunately, complete prevention information was found on less than a third of the sites."

Bichakjian and his colleagues note that the sites they found were perhaps not the best available, but that they are the most likely to come up in a basic Internet search. The use of special computer coding and registration with search engine companies can boost a site into the ranks of the most easily found, regardless of the quality of the information on the site.
Besides Bichakjian, Johnson and Biermann, the study's authors include clinical assistant dermatology professor Timothy Wang, M.D., dermatology lecturer Jennifer Schwartz, M.D., and senior research associate Janette Hall, M.S..

University of Michigan Health System

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to